These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 1107450)

  • 1. Host resistance to Serratia marcescens infection: serum bactericidal activity and phagocytosis by normal blood leukocytes.
    Simberkoff MS; Ricupero I; Rahal JJ
    J Lab Clin Med; 1976 Feb; 87(2):206-17. PubMed ID: 1107450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virulence of nosocomial isolates of Serratia marcescens for NMRI mice: correlation with O-antigens O6 and O14.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jul; 252(3):360-9. PubMed ID: 6182709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further characterization of "promptly" and "delayed" human serum-sensitive strains of Serratia marcescens.
    Traub WH; Fukushima PI
    Zentralbl Bakteriol Orig A; 1979 Dec; 245(4):495-511. PubMed ID: 44945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phagocytosis of Serratia marcescens by leukocytes of fresh defibrinated human blood: failure of "natural" human specific anti-O IgG antibodies to enhance phagocytosis.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 250(1-2):92-103. PubMed ID: 7032156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of Serratia marcescens to human serum: antagonism of serum bactericidal activity by IgG immunoglobulins of homologous rabbit anti-O sera.
    Traub WH
    Zentralbl Bakteriol A; 1980 Feb; 246(1):26-49. PubMed ID: 6158811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serratia marcescens: use of detailed characterization of strains to evaluate an increase of isolates in an intensive care unit.
    Cardos SF; Florman AL; Simberkoff MS; Lanier L
    Am J Med Sci; 1973 Dec; 266(6):447-52. PubMed ID: 4590096
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of a commercial, intravenously applicable IgG F (ab)2 preparation (Gamma-Venin) to enhance human serum bactericidal activity against Serratia marcescens.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 249(4):504-11. PubMed ID: 6171949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new method for measuring simultaneously the phagocytic and bactericidal capacity of human leukocytes.
    Grange MJ; Eche F; Dresch C; Najean Y
    Biomedicine; 1975 Dec; 23(10):414-8. PubMed ID: 769857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human serum bactericidal activity against Serratia marcescens: failure of human, "natural," specific anti-O IgG antibodies to enhance serum bactericidal activity.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 250(1-2):84-91. PubMed ID: 7032154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian serum susceptibility of Serratia marcescens: detection of three human serum susceptibility categories.
    Traub WH; Fukushima PI
    Zentralbl Bakteriol Orig A; 1979; 245(3):301-11. PubMed ID: 44784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Utility of serotyping in the study of Serratia marcescens infections in Strasbourg Hospitals (author's transl)].
    Minck R; Le Minor S; Pigache F; Dammron A; Reeb E; Kohen M; Le Faou A
    Pathol Biol (Paris); 1980 Oct; 28(8):501-7. PubMed ID: 7001322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional role of antibody against "core" glycolipid of Enterobacteriaceae.
    Young LS; Stevens P; Ingram J
    J Clin Invest; 1975 Oct; 56(4):850-61. PubMed ID: 1099119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serratia marcescens infections in a hospital: typing of isolated strains].
    Yde M
    Arch Belg; 1989; 47(5-6):189-210. PubMed ID: 2700064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of human serum bactericidal activity by specific IgM antibodies of normal and anti-O immune rabbit sera against pseudo-serum-resistant strains of Serratia marcescens.
    Traub WH
    Zentralbl Bakteriol A; 1980 Feb; 246(1):50-66. PubMed ID: 6999780
    [No Abstract]   [Full Text] [Related]  

  • 16. Opsonization requirements of Serratia marcescens.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Nov; 253(2):204-24. PubMed ID: 6187137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of vaccination against systemic Serratia infection.
    Kumagai Y; Okada K; Ishimaru T; Sawae Y; Kuroiwa A; Nomoto K
    J Clin Lab Immunol; 1989 Jul; 29(3):125-32. PubMed ID: 2699333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hospital infection due to Serratia marcescens and its sensitivity to antibiotics].
    Filloy L; Serrano D; Borjas E
    Bol Med Hosp Infant Mex; 1980; 37(5):871-7. PubMed ID: 7000092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes over a period of five years of Serratia marcescens endemia at the Centre Hospitalier de Strasbourg].
    Minck R; Le Minor S; Dammron A; Reeb E; Benazet F; Martin L; Lapeyre B
    Ann Biol Clin (Paris); 1983; 41(1):51-4. PubMed ID: 6346963
    [No Abstract]   [Full Text] [Related]  

  • 20. Defective polymorphonuclear-leukocyte function and chronic granulomatous disease in two female children.
    Quie PG; Kaplan EL; Page AR; Gruskay FL; Malawista SE
    N Engl J Med; 1968 May; 278(18):976-80. PubMed ID: 4868715
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.